Abstract:Reduction and pH dual-sensitive reversibly core-crosslinked polypeptide micelles were developed from lipoic acid (LA) and cis-1,2-cyclohexanedicarboxylic acid (CCA) decorated poly(ethylene glycol)-b-poly(L-lysine) (PEG-P(LL-CCA/LA)) block copolymers for active loading and triggered intracellular release of doxorubicin (DOX). PEG-P(LL18-CCA4/LA14) and PEG-P(LL18-CCA8/LA10) (M(n PEG) = 5.0 kg/mol) formed nano-sized micelles that were readily crosslinked in the presence of a catalytic amount of dithiothreitol (DTT) in phosphate buffer (pH 7.4, 10 mM). PEG-P(LL18-CCA4/LA14) micelles displayed an elevated DOX loading over PEG-P(LL14-LA14) controls likely due to presence of ionic interactions between DOX and CCA. These core-crosslinked polypeptide micelles while exhibiting high stability against extensive dilution and high salt concentration were quickly dissociated into unimers in the presence of 10 mM DTT. The in vitro release studies showed that DOX release from PEG-P(LL18-CCA4/LA14) micelles at pH 7.4 and 37 °C was significantly inhibited by crosslinking (i.e. less than 20% release in 24 h). The release of DOX was, however, doubled under endosomal pH of 5.0, possibly triggered by cleavage of the acid-labile amide bonds of CCA. In particular, rapid DOX release was observed under a reductive condition containing 10 mm glutathione (GSH), in which 86.0% and 96.7% of DOX were released in 24 h at pH 7.4 and 5.0, respectively, under otherwise the same conditions. MTT assays demonstrated that these core-crosslinked polypeptide micelles were practically non-toxic up to a tested concentration of 1.0 mg/mL, while DOX-loaded micelles caused pronounced cytotoxic effects to HeLa and HepG2 tumor cells with IC50 (inhibitory concentration to produce 50% cell death) of ca. 12.5 μg DOX equiv/mL following 48 h incubation. Confocal microscopy observations revealed that DOX-loaded crosslinked PEG-P(LL18-CCA4/LA14) micelles more efficiently delivered and released DOX into the nuclei of HeLa cells than PEG-P(LL14-LA14) counterparts. These dual-bioresponsive core-crosslinked polypeptide micelles have appeared as an advanced platform for targeted cancer therapy.

Preparation of ROS-responsive Core Crosslinked Polycarbonate Micelles with Thioketal Linkage.

ROS-responsive core crosslinked micelles by combination of enzymatic polymerization and thiol-ene click chemistry for anticancer drug delivery

Facile Preparation of Core Cross-Linked Nanomicelles Based on Graft Copolymers with Ph Responsivity and Reduction Sensitivity for Doxorubicin Delivery.

Preparation of pH and redox dual-sensitive core crosslinked micelles for overcoming drug resistance of DOX

Reduction and Ph Dual-Sensitive Core-Crosslinked Polypeptide Micelles for Triggered Doxorubicin Release

Preparation of core cross-linked PCL-PEG-PCL micelles for doxorubicin delivery in vitro.

A Reactive Oxygen Species-Responsive Prodrug Micelle with Efficient Cellular Uptake and Excellent Bioavailability.

Photodynamic Therapy-Triggered On-Demand Drug Release from ROS-responsive Core-Cross-linked Micelles Toward Synergistic Anti-Cancer Treatment

Reduction-responsive Disassemblable Core-Cross-linked Micelles Based on Poly(ethylene Glycol)-B-poly(n-2-hydroxypropyl Methacrylamide)-Lipoic Acid Conjugates for Triggered Intracellular Anticancer Drug Release.

Facile Preparation of Core Cross-Linked Micelles from Catechol-Containing Amphiphilic Triblock Copolymer

Reduction-sensitive reversibly crosslinked biodegradable micelles for triggered release of doxorubicin.

Fabrication of Core Crosslinked Polymeric Micelles as Nanocarriers for Doxorubicin Delivery: Self-Assembly, In Situ Diselenide Metathesis and Redox-Responsive Drug Release

Reduction/temperature/pH Multi-Stimuli Responsive Core Cross-Linked Polypeptide Hybrid Micelles for Triggered and Intracellular Drug Release.

Reduction-responsive core-shell-corona micelles based on triblock copolymers: novel synthetic strategy, characterization, and application as a tumor microenvironment-responsive drug delivery system.

Redox-responsive core cross-linked micelles based on cypate and cisplatin prodrugs-conjugated block copolymers for synergistic photothermal–chemotherapy of cancer

Multi-Activated Polymeric Micelles with Charge-Conversion and Ros-Controlled Drug Release for Efficient Cancer Therapy

A new biosafe reactive oxygen species (ROS)-responsive nanoplatform for drug delivery

Highly-controllable drug release from core cross-linked singlet oxygen-responsive nanoparticles for cancer therapy

Construction of pH-responsive core crosslinked micelles via thiol-yne click reaction

Reduction-Responsive Cross-Linked Micelles Based on Pegylated Polypeptides Prepared Via Click Chemistry

ROS-Responsive Polymeric Nanocarriers with Photoinduced Exposure of Cell-Penetrating Moieties for Specific Intracellular Drug Delivery